Filing Details
- Accession Number:
- 0001225208-17-003412
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-15 16:58:41
- Reporting Period:
- 2017-02-13
- Filing Date:
- 2017-02-15
- Accepted Time:
- 2017-02-15 16:58:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403373 | A John Deford | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Sr. Vp Sci Tech And Clin Afrs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-13 | 447 | $240.47 | 24,684 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-13 | 1,897 | $240.47 | 22,318 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-14 | 2,788 | $240.51 | 19,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 74 | Indirect | 401(k) Plan |
Footnotes
- Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $240.33 to $240.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Billionaire Hedge Funds
